SBIR-STTR Award

Topic 377: Symptom Management and Intervention Roadmaps (STaIRS) (Moonshot) Phase II
Award last edited on: 9/27/2021

Sponsored Program
SBIR
Awarding Agency
NIH : NCI
Total Award Amount
$1,725,000
Award Phase
2
Solicitation Topic Code
377
Principal Investigator
Carrie Stricker

Company Information

Carevive Systems Inc

11900 Biscayne Boulevard Suite 630
North Miami, FL 33181
   (305) 979-0068
   N/A
   www.carevive.com
Location: Single
Congr. District: 24
County: Miami-Dade

Phase I

Contract Number: 75N91018C00021-0-0-0
Start Date: 9/24/2018    Completed: 1/14/2022
Phase I year
2018
Phase I Amount
$225,000
Numerous adverse symptoms are under-detected in cancer care resulting1-3 in missed opportunities for intervention; leading to poor treatment adherence, avoidable hospitalizations, and worse morbidity and survival. The IOM proposed shaking up the current symptom paradigm from reactive to proactive, personalized, technology-enabled models of symptom care as a solution to this clinical quality crisis. Such proactive care models reduce symptom burden, emergency department use, and improve survival. While commercially-available symptom monitoring and clinical alerting applications proliferate, they lack personalized, computable algorithms for tailored, evidence-based clinical symptom management. The Carevive Care Planning System (CPS) is an exception, having commercially deployed symptom monitoring and assessment tools, clinician-facing content, and computable algorithms for patient self-management of symptoms since 2014, via a proprietary rules engine. These assets, combined with ONS content and Carevive’s extensive network of expert advisors and clients, will be leveraged in Phase I into the usercentered design of computable algorithms for clinician assessment and management of fatigue and constipation; integrating clinical data to facilitate personalized, evidence-based symptom care superior to existing reactive and proactive symptom care approaches. Phase I wireframes will be the basis for symptom expansion, extensive usability and field testing in Phase II, and ultimately efficacy testing and full-scale commercialization.

Project Terms:
Accident and Emergency department; Algorithms; Assessment tool; cancer care; Caring; Client; Clinical; Clinical Data; clinical decision support; commercialization; Constipation; data integration; design; efficacy testing; Ensure; Evaluation; evidence base; Fatigue; Fatigue Assessment and Management; field study; Guidelines; Hospitalization; improved; interoperability; Intervention; Logic; Modeling; Monitor; Morbidity - disease rate; Nursing Societies; Oncology; Oncology Nurse; Patients; Phase; Proliferating; reduce symptoms; symptom management; symptom self management; Symptoms; System; Technology; Telephone; Testing; Translating; treatment adherence; Triage; usability

Phase II

Contract Number: 261201800021C
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
2020
Phase II Amount
$1,500,000
Numerous adverse symptoms are under-detected in cancer care resulting1-3 in missed opportunities for intervention; leading to poor treatment adherence, avoidable hospitalizations, and worse morbidity and survival. The IOM proposed shaking up the current symptom paradigm from reactive to proactive, personalized, technology-enabled models of symptom care as a solution to this clinical quality crisis. Such proactive care models reduce symptom burden, emergency department use, and improve survival. While commercially-available symptom monitoring and clinical alerting applications proliferate, they lack personalized, computable algorithms for tailored, evidence-based clinical symptom management. The Carevive Care Planning System (CPS) is an exception, having commercially deployed symptom monitoring and assessment tools, clinician-facing content, and computable algorithms for patient self-management of symptoms since 2014, via a proprietary rules engine. These assets, combined with ONS content and Carevive’s extensive network of expert advisors and clients, will be leveraged in Phase I into the usercentered design of computable algorithms for clinician assessment and management of fatigue and constipation; integrating clinical data to facilitate personalized, evidence-based symptom care superior to existing reactive and proactive symptom care approaches. Phase I wireframes will be the basis for symptom expansion, extensive usability and field testing in Phase II, and ultimately efficacy testing and full-scale commercialization.